Loading
Latest filing published 08 Mar 2018 for Sonoma Pharmaceuticals, Inc., €7,948.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
James J. Schutz discloses dealings in Sonoma Pharmaceuticals, Inc. to SEC (Form 4). The record holds 7 filings, for trades running from 29 June 2017 to 8 March 2018.
Purchases make up the whole of the open-market record (5 purchases, €16k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 2 share grants. 2018 to date brings 1 purchase and no sales.
In size, the median ticket on the buying side is €1,698.
The latest filing, published on 8 March 2018, reports an open-market purchase of €7,948 in Sonoma Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations